Portfolio actions today.
AKO1L confirmed my suspicions about weakening outlook. Basically no profit in Q2. However, CFO today reminded, that QoQ comps can be misleading. They hold quite a lot of inventory in hopes to sell at higher prices in FY H2.
Reduced further by 33%, locking FIFO +61.8% profit at +25.2% CAGR
Increased VLP1L by 50% <€12.2. No expectations on Q4, simply maintaining exposure to OMXB. Focus on dividends, expecting continued management execution turning around MPK, ramping Bauska plant, core business.
And finally, increased $FIGR once again (still a tiny position though). 100%+ revenue growth YoY suits me well. Will be looking for earnings call and diluted share count next week.
AKO1L confirmed my suspicions about weakening outlook. Basically no profit in Q2. However, CFO today reminded, that QoQ comps can be misleading. They hold quite a lot of inventory in hopes to sell at higher prices in FY H2.
Reduced further by 33%, locking FIFO +61.8% profit at +25.2% CAGR
Increased VLP1L by 50% <€12.2. No expectations on Q4, simply maintaining exposure to OMXB. Focus on dividends, expecting continued management execution turning around MPK, ramping Bauska plant, core business.
And finally, increased $FIGR once again (still a tiny position though). 100%+ revenue growth YoY suits me well. Will be looking for earnings call and diluted share count next week.